Navigation Links
Verenium Announces $22.5 Million, Five-Year Secured Financing
Date:12/10/2012

cus, technologies, products and product candidates and product pipeline (including Verenium's ability to identify, develop and commercialize new products and product candidates, either independently or with collaborators or partners, and market demand for those products and product candidates), dependence on patents and proprietary rights,  protection and enforcement of its patents and proprietary rights, the commercial prospects of the industries in which Verenium operates and sells products, Verenium's dependence on manufacturing and/or license agreements,  its ability to achieve milestones under existing and future collaboration agreements, the ability of Verenium and its partners to commercialize its technologies and products (including by obtaining any required regulatory approvals) using Verenium's technologies, the timing for launching any commercial products and projects, the ability of Verenium and its collaborators to market and sell any products that it or they commercialize, the development or availability of competitive products or technologies, the future ability of Verenium to enter into and/or maintain collaboration and joint venture or partnership agreements and licenses on a timely basis or at all, and risks and other uncertainties more fully described in Verenium's filings with the Securities and Exchange Commission, including, but not limited to, Verenium's annual report on Form 10-K for the year ended December 31, 2011 and any updates contained in its subsequently filed quarterly reports on Form 10-Q.  These forward-looking statements speak only as of the date hereof, and Verenium expressly disclaims any intent or obligation to update these forward-looking statements.

Contacts:

Sarah Carmody

Manager, Corporate Communications

858-431-8581

sarah.carmody@verenium.com



'/>"/>
SOURCE Verenium Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
2. Verenium to Present at Baird Clean Technology Conference
3. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
4. Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results
5. Verenium Corporation To Announce First Quarter 2012 Financial Results
6. Verenium Corporation Named One Of The 2012 Best Places to Work in San Diego
7. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility
8. Verenium Announces EPA Authorization To Market Its Next-Generation Enzyme Breaker For Hydraulic Fracturing
9. Verenium Corporation To Announce Second Quarter 2012 Financial Results
10. Verenium Reports Financial Results For The Second Quarter And Six Months Ended June 30, 2012
11. Verenium Corporation To Announce Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... 2015 , ... Co-located major European conferences in optical metrology ... Nobel Laureates who presented during an International Year of Light (IYL2015) ... SPIE Optical Metrology (SPIE OM) and the SPIE/OSA European Conferences on ...
(Date:7/7/2015)... , July 7, 2015 ... - Gene Therapy Market Analysis" report is an ... gene therapy field. Using detailed company data, deal ... provides an in-depth analysis of the current and ... The report discusses the key factors shaping and ...
(Date:7/7/2015)... 7, 2015 Genes in Space, a ... is landing at New England Biolabs® (NEB®) along ... of scientific exploration and celebration, on Thursday, July ... between Boeing®, The Center for Advancement of Science ... students to design an experiment to solve a ...
(Date:7/7/2015)... Mass. (PRWEB) , ... July 07, 2015 , ... ... a growing demand for biologic are some of the factors driving the pharmaceutical ... of drug manufacturers, as well as contract manufacturing organizations (CMOs), are driving market ...
Breaking Biology Technology:Light-Based Technologies at Work: ‘Seeing’ Through Walls, Monitoring Cancer Treatments and Air Pollution, Preserving Artworks -- and Much More 2Light-Based Technologies at Work: ‘Seeing’ Through Walls, Monitoring Cancer Treatments and Air Pollution, Preserving Artworks -- and Much More 3Light-Based Technologies at Work: ‘Seeing’ Through Walls, Monitoring Cancer Treatments and Air Pollution, Preserving Artworks -- and Much More 4Light-Based Technologies at Work: ‘Seeing’ Through Walls, Monitoring Cancer Treatments and Air Pollution, Preserving Artworks -- and Much More 5PharmaSphere: Emerging Biotechnologies - Gene Therapy Market Analysis 2Genes in Space finalists attend laboratory workshop and celebration at New England Biolabs' headquarters 2More Drug Companies Increasing Outsourcing Budgets; CMO Partners Spring Up as Market Thrives, According to BCC Research 2More Drug Companies Increasing Outsourcing Budgets; CMO Partners Spring Up as Market Thrives, According to BCC Research 3
... ST. LOUIS, May 13 Sigma-Aldrich (Nasdaq: ... www.sigma.com/precisiokinases ), a new collection of ... enable scientists to achieve greater insight into protein ... kinase screening and profiling, Precisio Kinases allow for ...
... May 13 EFT BioTech Holdings, Inc. (Pink Sheets: ... International Marine Corporation, received the first permit to ferry ... China. Excalibur,s OceanLaLa vessel is 207 foot long, ... 300 tons of cargo and 370 passengers.In November 2008, ...
... joined the American Civil Liberties Union (ACLU) in a ... -- specifically, patents covering the BRCA1 and BRCA2 genes, ... The lawsuit was filed against the U.S. Patent and ... of Utah Research Foundation in U.S. District Court in ...
Cached Biology Technology:Sigma-Aldrich Introduces Precisio(TM) Kinases for High-Throughput Screening and Kinase Profiling 2EFT BioTech Holdings, Inc.'s Subsidiary Receives First Permit to Cross Taiwan Strait 2EFT BioTech Holdings, Inc.'s Subsidiary Receives First Permit to Cross Taiwan Strait 3ASCP Joins ACLU Lawsuit Opposing Gene Patents 2ASCP Joins ACLU Lawsuit Opposing Gene Patents 3
(Date:7/7/2015)... Research and Markets ... the "Capacitive Fingerprint Sensors Patent Landscape" ... date, fingerprint sensing technology is the most reliable ... well developed. This patent landscape focuses on fingerprint ... domain of capacitive fingerprint sensors is closely linked ...
(Date:7/7/2015)... July 7, 2015  Based on its recent ... Sullivan recognizes Credence ID, LLC with the 2015 ... of the Year Award. Credence ID has developed ... its mission of offering enrollment and identification solutions ... Credence ID was formed by experts from the ...
(Date:7/7/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... commerce market announces a revised version of one of its first ... air on CNBC in New York , ... San Francisco metro areas.    ... ability to replace all the cards in your wallet and keep ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... Md., April 7, 2011 The American Society for ... associate professor at University of Massachusetts Medical School, the ... present his award lecture, titled "Three-dimensional Folding of Genomes," ... Biology conference at the Walter E. Washington Convention Center ...
... to even one of the thousands of DNA codes that ... in severe diseases such as cancer, cystic fibrosis, muscular dystrophy ... of a virus or bacteria can give rise to drug ... standard drug therapies. For these reasons, scientists have long sought ...
... gene introduced into soybean plants has increased the amount of ... helping meet nutritional needs of a hungry world. Eve ... Li, an adjunct assistant professor and an associate scientist working ... Arabidopsis plants into soybean plants and increased the amount of ...
Cached Biology News:UMass med school professor wins coveted emerging-investigator award 2UMMS researchers develop new technology to screen and analyze genetic mutations 2UMMS researchers develop new technology to screen and analyze genetic mutations 3Starch-controlling gene fuels more protein in soybean plants 2
Request Info...
Prepared with distilled water. Yeast extract solution is autolyzed at 150 g/L....
Streptomycin sulfate an aminoglycoside used for bacterial selection binds to the small ribosomal subunit and interferes with protein biosynthesis.21H39N7O12)2x3H2SO4Formula weight:...
...
Biology Products: